Literature DB >> 8013521

Coronary disease: are there gender differences?

M E Kitler1.   

Abstract

Prevalence rates from hypertensive heart disease are higher for women, while men have higher prevalence rates for coronary heart disease. Female gender is associated with increased mortality after acute MI. Females have also been shown to respond differently to men to a host of approaches to CHD. Both surgical and pharmacological interventions appear to be less effective in females than in males. Answers are still needed, but they have not been forthcoming because, in general, inadequate numbers of females were included in most applicable clinical trials. It may be that males are over-treated rather than that females are under-treated. It is incorrect to extrapolate findings in men to women, given the differences. Studies are needed to determine what intervention strategies in the primary prevention and treatment of coronary disease should be used for women and the elderly.

Entities:  

Mesh:

Year:  1994        PMID: 8013521     DOI: 10.1093/oxfordjournals.eurheartj.a060515

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

Review 1.  The changing face of hypertension and antihypertensive agents.

Authors:  M E Kitler
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

2.  Longer pre-hospital delay in acute myocardial infarction in women because of longer doctor decision time.

Authors:  J Bouma; J Broer; J Bleeker; E van Sonderen; B Meyboom-de Jong; M J DeJongste
Journal:  J Epidemiol Community Health       Date:  1999-08       Impact factor: 3.710

Review 3.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

4.  Gender differences in presentation and diagnosis of chest pain in primary care.

Authors:  Stefan Bösner; Jörg Haasenritter; Maren A Hani; Heidi Keller; Andreas C Sönnichsen; Konstantinos Karatolios; Juergen R Schaefer; Erika Baum; Norbert Donner-Banzhoff
Journal:  BMC Fam Pract       Date:  2009-12-14       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.